IVCC
The IVCC is a Product Development Partnership (PDP) established as a not for profit company and registered charity to overcome the barriers to innovation in the development of new insecticides for public health vector control and to develop information systems and tools which will enable new and existing pesticides to be used more effectively.
Objects
THE PRESERVATION AND PROTECTION OF GOOD HEALTH AND THE RELIEF OF SICKNESS BY ALLEVIATINGAND PREVENTING THE SPREAD OF ANY TYPE OF TROPICAL DISEASE WHICH IS NOW OR MAY HEREAFTERBECOME KNOWN IN ANY PART OF THE WORLD WHERE SUCH DISEASE EITHER MANIFESTS ITSELF OR HASEFFECTS BY ANY MEANS, AND IN PARTICULAR BUT WITHOUT PREJUDICE TO THE GENERALITY OF THEFOREGOING BY:3.1 STIMULATING INDUSTRY AND ACADEMIA TO DISCOVER, DEVELOP AND DELIVER NEW TOOLS TOBETTER MANAGE INSECTS WHICH TRANSMIT DISEASE AND TO MONITOR AND BETTER DIRECTTHE USE OF THESE TOOLS.3.2 PROMOTING AND ENCOURAGING THE DISSEMINATION OF NEW SCIENTIFIC INFORMATION.3.3 ENSURING THE PRODUCTS AND SYSTEMS DEVELOPED ARE ACCESSIBLE TO THOSE IN NEED OFTHEM IN THE DEVELOPING COUNTRIES OF THE WORLD.3.4 PROMOTING AND CONDUCTING RESEARCH INTO ISSUES CONCERNING PUBLIC HEALTH.
Financial health, per its FY2025 accounts
The accounts state that the charity generated a surplus of £1.8m for the year ended 31 July 2025, resulting in total free/unrestricted reserves of £13.0m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future, citing a positive bank balance of £9.1m and significant deferred income. The financial position is supported by a strong asset base and medium-term funding visibility from major donors.
What the accounts disclose
“FCDO accounted for 54% of the charity’s income in the year, up from 33% in 2024.” — page 12
“IVCC aligns with the group policy of ensuring that unrestricted reserves represent a minimum of 6 months' pay expenditure (£1.6m).” — page 13
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/07/2025
- Government income: £9,145,000 — contracts £9,145,000 (1); 48% of the £19,097,000 total gross income on the same return
- Employees paid over £60,000: 12 (£70,001–£80,000: 1; £80,001–£90,000: 4; £90,001–£100,000: 3; £100,001–£110,000: 1; £110,001–£120,000: 1; £120,001–£130,000: 1; £200,001–£250,000: 1)
Self-declared on the annual return for the financial year ending 31/07/2024
- Government income: £6,072,000 — contracts £6,072,000 (1); 30% of the £20,347,000 total gross income on the same return
- Employees paid over £60,000: 11 (£70,001–£80,000: 2; £80,001–£90,000: 4; £90,001–£100,000: 1; £110,001–£120,000: 2; £120,001–£130,000: 1; £200,001–£250,000: 1)
Self-declared on the annual return for the financial year ending 31/07/2023
- Government income: £5,242,000 — contracts £5,242,000 (1); 16% of the £33,436,000 total gross income on the same return
- Employees paid over £60,000: 11 (£60,001–£70,000: 1; £70,001–£80,000: 3; £80,001–£90,000: 3; £90,001–£100,000: 1; £100,001–£110,000: 1; £110,001–£120,000: 2)
Leadership, per the charity’s website
- Justin McBeath — Chief Executive Officer
- Chris Larkin — Director
- Mathias Mondy — Director
- Dr Derric Nimmo — Director
- Leo Smedley — Director
- David Worrall — Director
Funders the charity credits
- Global Fund
- Unitaid
- USAID
Structured financials (annual return, FY ending 31/07/2025)
Trustees
- Sherwin Charleschair
- Alan Court
- Dr Bruno Suzette Roger Moonen
- Dr Elizabeth Chizema
- Dr Jacqueline Applegate
- Jonathan Schofield
- Ray Nishimoto
- Susan Russell
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £19.1m | £17.3m |
| 31/07/2024 | £20.3m | £20.2m |
| 31/07/2023 | £33.4m | £32.3m |
| 31/07/2022 | £48.6m | £47.5m |
| 31/07/2021 | £39.4m | £38.2m |
Common questions
Is IVCC financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a surplus of £1.8m for the year ended 31 July 2025, resulting in total free/unrestricted reserves of £13.0m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future, citing a positive bank balance of £9.1m and significant deferred income. The financial position is supported by a strong asset base and medium-term funding visibility from major donors. Its FY2025 accounts were audited by Crowe U.K. LLP.
Charities like this
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| IVCC | £19.1m | — | — | unclear | — | no doubt |
| THE COLLABORATIVE INTERNATIONAL PESTICIDES ANALYTICAL COUNCIL LIMITED | £64k | — | 0 | unclear | — | no doubt |